Cumurcu, TongabayCumurcu, Birgül ElbozanZayman, Esra PorgalıÇavdar, MüfideNurlu, KayhanDoğanay, Selim2020-05-272020-05-272017Tongabay C., Birgül ELBOZAN C., Esra PORGALI Z., Müfide Ç., Kayhan N., Selim D. (2017). Presumed Central Serous Retinopathy Due to Sertraline (Sertraline Retinopathy), Retina-Vitreus, İnönü Üniversitesi, Malatya.1300-12562717-7149https://hdl.handle.net/11616/15598https://search.trdizin.gov.tr/yayin/detay/296698Öz:A 36 year-old male patient who developed central serous retinop- athy (CSR) presumed to result from intake of sertraline hydro- chloride (100 mg per day) during one year. A complete ocular examination, color vision testing, automated static perimetry, optical coherence tomography (OCT) and fun- dus fl uorescein angiography (FFA) were performed. OCT and FFA fi ndings were revealed a central serous retinopathy in the right eye in a patient who use sertraline for more than a year. In conclussion, the patients who use sertralin should be aware of the potential risk of developing CSR or the other macular changes. Başlık (Türkçe):Muhtemel Sertraline Bağlı Santral Seroz Retinopati Öz (Türkçe):Öz: A 36 year-old male patient who developed central serous retinop- athy (CSR) presumed to result from intake of sertraline hydro- chloride (100 mg per day) during one year. A complete ocular examination, color vision testing, automated static perimetry, optical coherence tomography (OCT) and fun- dus fl uorescein angiography (FFA) were performed. OCT and FFA fi ndings were revealed a central serous retinopathy in the right eye in a patient who use sertraline for more than a year. In conclussion, the patients who use sertralin should be aware of the potential risk of developing CSR or the other macular changes. Başlık (Türkçe): Muhtemel Sertraline Bağlı Santral Seroz Retinopati Öz (Türkçe):trinfo:eu-repo/semantics/openAccessGöz HastalıklarıArticle26269271296698